CAI

Caris Life Sciences, Inc. develops and commercializes solutions to transform healthcare through comprehensive molecular profiling, including Whole Genome, Whole Exome, and Whole Transcriptome Sequencing. The company utilizes advanced AI and machine learning to create a large-scale clinico-genomic database for analyzing the molecular complexity of disease. Caris provides precision medicine diagnostic solutions for early detection, diagnosis, monitoring, therapy selection, and drug development. Headquartered in Irving, Texas, Caris operates in the U.S. and international markets.